Also: galanthamine
U.S. Preparations:
Razadyne™ (Reminyl® Janssen) FDA approved:
6.22.2001 for treatment of
mild to moderate dementia of the Alzheimer's
type
U.S. Prescribing information

| Dose: |
4 mg. |
8 mg. |
12 mg. |
| Color: |
off-white |
pink |
orange-brown |
| Shape: |
circular biconvex |
| Type: |
film-coated tablet |
| Imprint: |
Janssen
|
| G4 |
G8 |
G12 |
Razadyne™ ER (Reminyl® Janssen) FDA approved:
12.22.2004 for treatment of
mild to moderate dementia of the Alzheimer's
type
U.S. Prescribing information

Preparations Outside U.S.:
|